Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-15

Study Completion Date

2027-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To establish the efficacy of a community-based POL (Popular Opinion Leader) intervention with two different trainings designed to increase COVID-19 vaccine and booster uptake and reduce hesitancy among social networks of Black individuals with rheumatic conditions. The investigators will also determine the structure and composition of the personal and outreach social networks of POLs.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Arthritis Patient Education for Urban African Americans

NCT00000396

Arthritis

COMPLETED NA

Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases

NCT00069342

Rheumatoid Arthritis Systemic Lupus Erythematosus Arthritis

COMPLETED

Testimonials and Navigation in Rheumatology

NCT06469788

Rheumatologic Disease Autoimmune Diseases

RECRUITING NA

Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology

NCT05116163

Systemic Lupus Erythematosus Rheumatoid Arthritis Inflammatory Arthritis +1 more

COMPLETED NA

Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity

NCT05715463

Rheumatoid Arthritis Palindromic Arthritis Juvenile Rheumatoid Arthritis +11 more

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Through community-academic partnerships in Boston and Chicago, investigators will recruit and randomly assign POLs who identify as Black with rheumatic conditions to two training arms in each city. Arms 1 and 2 will receive the same core curriculum addressing COVID-19 vaccine hesitancy, safety and efficacy. POLs will work in their communities to distributed information they learned in the trainings to members of their social network. The investigators will gather information about these social networks, assessing for differences in characteristics such as size, location, and who is in it (percentage of family, percentage Black, percentage with rheumatic conditions).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatic Diseases COVID-19 Vaccine COVID-19 SLE

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two different group training arms related to COVID-19 vaccine uptake

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Participants are unblinded but study has non-disclosure component of keeping the difference between the two training arms as non-disclosed until the conclusion of the study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COVID-19 vaccine and booster training

Group training involving COVID-19 vaccine and booster information, including background, development, and myths.

Group Type ACTIVE_COMPARATOR

COVID-19 vaccine and booster training, and importance

Intervention Type BEHAVIORAL

COVID-19 vaccine and booster information training

COVID-19 vaccine and booster training with extra undisclosed component

Group training involving COVID-19 vaccine and booster information, including background, development, and myths. Contains extra training component that is undisclosed until the end of the study so as not to introduce bias.

Group Type EXPERIMENTAL

COVID-19 vaccine and booster training, and importance

Intervention Type BEHAVIORAL

COVID-19 vaccine and booster information training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

COVID-19 vaccine and booster training, and importance

COVID-19 vaccine and booster information training

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

POLs:

18-85 years old; All genders; English-speaking; Self-identify as Black and/or African descent; Received ≥1 dose of a COVID-19 vaccine after 8.31.2022 (bivalent booster or updated COVID-19 vaccine \[2023-2024\] formula)

Social network members:

At least 18 years of age; All genders; English-speaking or Haitian Creole or Spanish-speaking if the POL also speaks Haitian Creole or Spanish; Not have received the updated COVID-19 vaccine 2023-2024 formula; Recent (within 3 months) COVID-19 infection and either undecided or no intention of receiving the vaccine.

Exclusion Criteria

Both POLs and social network members:

Under 18 years of age Pregnant women Institutionalized or incarcerated Those who are up to date on COVID vaccinations

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes